NEW YORK, March 18 - DeCode Genetics on Monday said it has sealed its acquisition of MediChem Life Sciences as shareholders "voted overwhelmingly" to support the stock-for-stock deal.
All other closing conditions have also been met, DeCode said.
Registering provides access to this and other free content.
Already have an account?Login Now.
Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.